State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Uterus (Corpus & Uterus, NOS) (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 7.0 with a 95% confidence interval from 7.0 to 7.1 and 14,797 average annual cases over 2016-2020.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 26.0

California³

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.8 to 8.2 and 1,914 average annual cases over 2016-2020.
• CI*Rank⋔ : 6 (5, 10)
• Percent of Cases with Late Stage : 29.8

New York³

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.6 to 9.1 and 1,208 average annual cases over 2016-2020.
• CI*Rank⋔ : 3 (1, 5)
• Percent of Cases with Late Stage : 29.0

Florida⁶

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 7.0 to 7.4 and 1,156 average annual cases over 2016-2020.
• CI*Rank⋔ : 16 (10, 21)
• Percent of Cases with Late Stage : 28.3

Texas³

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.2 to 6.6 and 1,024 average annual cases over 2016-2020.
• CI*Rank⋔ : 29 (21, 38)
• Percent of Cases with Late Stage : 26.8

Pennsylvania⁶

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.5 to 8.1 and 735 average annual cases over 2016-2020.
• CI*Rank⋔ : 8 (5, 13)
• Percent of Cases with Late Stage : 24.3

Illinois³

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.6 to 8.1 and 667 average annual cases over 2016-2020.
• CI*Rank⋔ : 7 (5, 13)
• Percent of Cases with Late Stage : 26.4

Ohio⁶

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 7.0 to 7.6 and 599 average annual cases over 2016-2020.
• CI*Rank⋔ : 13 (9, 21)
• Percent of Cases with Late Stage : 24.2

New Jersey³

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.2 to 8.8 and 531 average annual cases over 2016-2020.
• CI*Rank⋔ : 5 (2, 6)
• Percent of Cases with Late Stage : 27.0

Michigan⁶

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 7.1 to 7.7 and 522 average annual cases over 2016-2020.
• CI*Rank⋔ : 12 (7, 19)
• Percent of Cases with Late Stage : 26.2

Georgia³

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.5 to 8.1 and 517 average annual cases over 2016-2020.
• CI*Rank⋔ : 9 (5, 14)
• Percent of Cases with Late Stage : 32.2

North Carolina⁶

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.4 to 6.9 and 477 average annual cases over 2016-2020.
• CI*Rank⋔ : 23 (17, 35)
• Percent of Cases with Late Stage : 26.2

Virginia⁶

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.1 to 6.7 and 360 average annual cases over 2016-2020.
• CI*Rank⋔ : 34 (20, 40)
• Percent of Cases with Late Stage : 24.8

Massachusetts³

• Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.7 to 7.4 and 340 average annual cases over 2016-2020.
• CI*Rank⋔ : 17 (10, 28)
• Percent of Cases with Late Stage : 24.7

Washington⁵

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.4 to 7.1 and 319 average annual cases over 2016-2020.
• CI*Rank⋔ : 20 (14, 34)
• Percent of Cases with Late Stage : 25.2

Maryland⁶

• Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.1 to 7.9 and 314 average annual cases over 2016-2020.
• CI*Rank⋔ : 10 (6, 20)
• Percent of Cases with Late Stage : 27.5

Wisconsin⁶

• Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.1 to 7.9 and 302 average annual cases over 2016-2020.
• CI*Rank⋔ : 11 (6, 21)
• Percent of Cases with Late Stage : 24.8

Missouri⁶

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 6.3 to 7.0 and 283 average annual cases over 2016-2020.
• CI*Rank⋔ : 22 (15, 37)
• Percent of Cases with Late Stage : 24.7

Arizona⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.3 to 6.0 and 267 average annual cases over 2016-2020.
• CI*Rank⋔ : 45 (34, 48)
• Percent of Cases with Late Stage : 24.7

Tennessee⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.4 to 6.0 and 263 average annual cases over 2016-2020.
• CI*Rank⋔ : 44 (34, 48)
• Percent of Cases with Late Stage : 23.2

Minnesota⁶

• Rate : The incidence rate is 6.5 with a 95% confidence interval from 6.1 to 6.9 and 237 average annual cases over 2016-2020.
• CI*Rank⋔ : 27 (17, 40)
• Percent of Cases with Late Stage : 21.6

Connecticut³

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.1 to 9.1 and 223 average annual cases over 2016-2020.
• CI*Rank⋔ : 4 (1, 8)
• Percent of Cases with Late Stage : 29.7

South Carolina⁶

• Rate : The incidence rate is 6.0 with a 95% confidence interval from 5.7 to 6.4 and 220 average annual cases over 2016-2020.
• CI*Rank⋔ : 38 (25, 46)
• Percent of Cases with Late Stage : 26.3

Colorado⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.3 to 6.1 and 200 average annual cases over 2016-2020.
• CI*Rank⋔ : 43 (32, 48)
• Percent of Cases with Late Stage : 25.7

Louisiana³

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.0 to 6.8 and 197 average annual cases over 2016-2020.
• CI*Rank⋔ : 32 (17, 42)
• Percent of Cases with Late Stage : 31.2

Kentucky³

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 6.2 to 7.0 and 196 average annual cases over 2016-2020.
• CI*Rank⋔ : 25 (14, 40)
• Percent of Cases with Late Stage : 24.3

Oregon⁶

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 6.0 to 6.8 and 179 average annual cases over 2016-2020.
• CI*Rank⋔ : 30 (17, 42)
• Percent of Cases with Late Stage : 21.1

Alabama⁶

• Rate : The incidence rate is 4.5 with a 95% confidence interval from 4.2 to 4.9 and 157 average annual cases over 2016-2020.
• CI*Rank⋔ : 49 (46, 49)
• Percent of Cases with Late Stage : 23.4

Oklahoma⁶

• Rate : The incidence rate is 6.1 with a 95% confidence interval from 5.6 to 6.5 and 151 average annual cases over 2016-2020.
• CI*Rank⋔ : 37 (21, 46)
• Percent of Cases with Late Stage : 25.7

Iowa³

• Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.3 to 7.4 and 147 average annual cases over 2016-2020.
• CI*Rank⋔ : 19 (10, 37)
• Percent of Cases with Late Stage : 22.9

Puerto Rico⁶

• Rate : The incidence rate is 6.5 with a 95% confidence interval from 6.0 to 7.0 and 140 average annual cases over 2016-2020.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : 21.3

Mississippi⁶

• Rate : The incidence rate is 6.3 with a 95% confidence interval from 5.8 to 6.9 and 126 average annual cases over 2016-2020.
• CI*Rank⋔ : 35 (16, 45)
• Percent of Cases with Late Stage : 27.3

Arkansas⁶

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.3 to 6.3 and 119 average annual cases over 2016-2020.
• CI*Rank⋔ : 41 (25, 48)
• Percent of Cases with Late Stage : 24.1

Kansas⁶

• Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.7 to 6.7 and 115 average annual cases over 2016-2020.
• CI*Rank⋔ : 36 (18, 46)
• Percent of Cases with Late Stage : 23.8

New Mexico³

• Rate : The incidence rate is 7.3 with a 95% confidence interval from 6.6 to 7.9 and 101 average annual cases over 2016-2020.
• CI*Rank⋔ : 14 (5, 34)
• Percent of Cases with Late Stage : 30.4

West Virginia⁶

• Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.6 to 8.0 and 98 average annual cases over 2016-2020.
• CI*Rank⋔ : 15 (5, 34)
• Percent of Cases with Late Stage : 21.9

Utah³

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 5.8 to 7.0 and 95 average annual cases over 2016-2020.
• CI*Rank⋔ : 31 (14, 45)
• Percent of Cases with Late Stage : 24.2

Hawaii³

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 8.9 to 10.8 and 92 average annual cases over 2016-2020.
• CI*Rank⋔ : 1 (1, 5)
• Percent of Cases with Late Stage : 30.2

Nebraska⁶

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 5.9 to 7.3 and 79 average annual cases over 2016-2020.
• CI*Rank⋔ : 24 (10, 45)
• Percent of Cases with Late Stage : 24.5

Idaho³

• Rate : The incidence rate is 6.7 with a 95% confidence interval from 6.0 to 7.5 and 72 average annual cases over 2016-2020.
• CI*Rank⋔ : 21 (9, 43)
• Percent of Cases with Late Stage : 26.4

Maine⁶

• Rate : The incidence rate is 5.7 with a 95% confidence interval from 5.1 to 6.4 and 61 average annual cases over 2016-2020.
• CI*Rank⋔ : 42 (21, 48)
• Percent of Cases with Late Stage : 18.5

New Hampshire⁶

• Rate : The incidence rate is 5.8 with a 95% confidence interval from 5.2 to 6.6 and 59 average annual cases over 2016-2020.
• CI*Rank⋔ : 40 (18, 48)
• Percent of Cases with Late Stage : 19.3

Delaware⁶

• Rate : The incidence rate is 6.9 with a 95% confidence interval from 6.1 to 7.9 and 51 average annual cases over 2016-2020.
• CI*Rank⋔ : 18 (6, 44)
• Percent of Cases with Late Stage : 24.3

Rhode Island⁶

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 5.6 to 7.3 and 48 average annual cases over 2016-2020.
• CI*Rank⋔ : 33 (9, 47)
• Percent of Cases with Late Stage : 22.3

Montana⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 4.8 to 6.4 and 41 average annual cases over 2016-2020.
• CI*Rank⋔ : 46 (22, 49)
• Percent of Cases with Late Stage : 21.9

District of Columbia⁶

• Rate : The incidence rate is 9.7 with a 95% confidence interval from 8.3 to 11.2 and 37 average annual cases over 2016-2020.
• CI*Rank⋔ : 2 (1, 10)
• Percent of Cases with Late Stage : 31.7

Vermont⁶

• Rate : The incidence rate is 6.4 with a 95% confidence interval from 5.4 to 7.6 and 32 average annual cases over 2016-2020.
• CI*Rank⋔ : 28 (6, 48)
• Percent of Cases with Late Stage : 20.2

South Dakota⁶

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 4.3 to 6.1 and 30 average annual cases over 2016-2020.
• CI*Rank⋔ : 47 (26, 49)
• Percent of Cases with Late Stage : 19.9

Alaska⁶

• Rate : The incidence rate is 6.6 with a 95% confidence interval from 5.4 to 7.9 and 26 average annual cases over 2016-2020.
• CI*Rank⋔ : 26 (5, 48)
• Percent of Cases with Late Stage : 23.7

North Dakota⁶

• Rate : The incidence rate is 5.9 with a 95% confidence interval from 4.9 to 7.0 and 26 average annual cases over 2016-2020.
• CI*Rank⋔ : 39 (11, 49)
• Percent of Cases with Late Stage : 22.7

Wyoming⁶

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.0 to 6.2 and 18 average annual cases over 2016-2020.
• CI*Rank⋔ : 48 (22, 49)
• Percent of Cases with Late Stage : 21.8

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : data not available

Nevada⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 10/04/2023 10:06 pm.

State Cancer Registries may provide more current or more local data.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
³ Source: SEER November 2022 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.